In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes

BACKGROUND: Autologous chondrocyte implantation (ACI) has been used over the last two decades to treat focal cartilage lesions aiming to delay or prevent the onset of osteoarthritis; however, some patients do not respond adequately to the procedure. A number of biomarkers that can forecast the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Ashraful, Fossum, Vegard, Hansen, Ann Kristin, Urbarova, Ilona, Knutsen, Gunnar, Martinez-Zubiaurre, Inigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329094/
https://www.ncbi.nlm.nih.gov/pubmed/30630436
http://dx.doi.org/10.1186/s12891-018-2380-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329094/
https://www.ncbi.nlm.nih.gov/pubmed/30630436
http://dx.doi.org/10.1186/s12891-018-2380-4

Ejemplares similares